EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement MarketWatch (press release) ROCKVILLE, Md., May 10, 2012 /PRNewswire via COMTEX/ — EntreMed, Inc. (UTD:ENMD) , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received notice from the Nasdaq Stock Market …